BPA Call 36C25723A0027-36C25725N0242

Award Date 6/5/25
Potential Completion Date 6/6/26
Potential Value $16K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Mdxhealth, Inc., a for-profit healthcare company, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract, a Blanket Purchase Agreement (BPA) call under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule, is valued at $430,183.13. The contract is for the provision of proprietary genetic testing services to support patient diagnosis, particularly for cancer, for the VA's Veterans Integrated...
This federal contract award provides $38,403.71 in funding to Mdxhealth, Inc. to deliver medical laboratory testing and analysis services to the Veterans Integrated Service Network (VISN) 19 of the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call against Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule contract for medical laboratory testing. Mdxhealth, a for-profit healthcare company, will provide a range of...
This federal contract award to Mdxhealth, Inc. is for providing medical laboratory testing and analysis services to the Veterans Integrated Service Network (VISN) 19 of the U.S. Department of Veterans Affairs (VA). The contract, valued at $141,530.28, is a Blanket Purchase Agreement (BPA) call against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The services to be provided include cancer diagnostic testing such as Oncotype DX and ConfirmMDx for...
This federal contract award, valued at $151,131.00, was made by the Veterans Integrated Service Network (VISN) 8, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The contract is for the provision of prostate cancer testing services, which will be delivered through a Blanket Purchase Agreement (BPA) under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule. Mdxhealth, a multinational healthcare company specializing in cancer...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Mdxhealth, Inc., a for-profit organization, to provide proprietary genetic testing services in support of patient diagnosis, such as for cancer. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's existing Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract has a potential value of $232,732.75 and a completion date of...
This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Mdxhealth, Inc., a for-profit organization that provides molecular diagnostic services and information to personalize the diagnosis and treatment of cancer. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's existing Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, with a potential value of $429,495.00. The contract is for proprietary...
This federal contract is for the provision of prostate cancer diagnostic testing services by Mdxhealth, Inc. to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The contract has a period of performance from October 1, 2020 to September 20, 2021, with a completion date of March 31, 2022. It is a firm fixed price delivery order issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule...
This is a federal contract award to Mdxhealth, Inc., a for-profit healthcare company, for DX Prostate Testing services. The contract, valued at $27,657.57, was awarded by the Veterans Integrated Service Network (VISN) 17, a division of the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) Call order placed under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The award has no set-aside designation and the...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call to MdxHealth, Inc. to provide prostate cancer testing services. The contract has a potential value of $151,131.00 and will run through June 30, 2025. This award is under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract vehicle. MdxHealth, a for-profit healthcare company, has previously provided cancer diagnostic services to various VA...
This is a delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21), a regional network of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company. The $1,132,338.36 firm-fixed-price contract is for Oncotype DX GPS (Genomic Prostate Score) testing services to be performed at the Mather, CA location. This order is issued under Mdxhealth's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services....

This federal contract award to MdxHealth, Inc. is for $15,964.65 under a Blanket Purchase Agreement (BPA) call against the Veterans Affairs (VA) Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is to provide the VA's Veterans Integrated Service Network (VISN) 17 with MdxHealth's GPS diagnostic testing services, which utilize molecular and genetic biomarkers to assist in the diagnosis and treatment of various cancers affecting veterans. This award builds upon MdxHealth's history of providing cancer testing services to the VA through prior IDIQs and BPAs across multiple VISN networks and VA healthcare facilities. The contract does not have a set-aside designation and is intended to support quality healthcare for veterans through June 2026.

Generated 3/12/25, 9:50 AM